Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New NICE (UK National Institute for Clinical Excellence) technology appraisal/appeal processes:

This article was originally published in Clinica

Executive Summary

The UK's National Institute for Clinical Excellence (NICE) has today (May 4 2004) published details of its new appraisal and appeal methods and processes. They feature an improved pre-appraisal scoping of the topic; longer appraisal consultation times; more detailed description of the methods for evaluating clinical and economic evidence, incorporating the use of a reference case; and more information on how the cost-effectiveness of technologies is assessed. Appraisals carried out under NICE's latest (9th) agreed wave of topics and those that are yet to be referred in the 10th wave will be appraised under a combination of the existing and new appraisal processes. The new process will come on stream fully for the 11th wave. Guides for use by manufacturers on submitting evidence to NICE will be published later this year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts